Goldman-Backed Biotech Attovia Raises $289 Million in US IPO
Original Report
Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its...
Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.
Glass House Analysis
Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
China’s AI Agent Unicorn Lovart Is Said to Explore Hong Kong IPO
Evoken, the Chinese startup behind AI design agent Lovart, is considering an initial public offering in Hong Kong, people familiar with the matter said, the latest such firm seeking to tap booming...
SK Hynix Climbs as Investors Bet on Shareholder Return Plan
Shares of SK Hynix Inc. advanced, lifted by an overnight rally in US chipmakers and speculation that the Korean firm may soon unveil buybacks and other details of a broader shareholder return plan.
LIC’s Big Share Sale Draws Investors Even as India’s IPO Market Stalls
India expands the size of the offering to raise $3.3 billion amid strong demand.
GM, Chinese automaker extend joint venture for 20 years despite geopolitical tensions with U.S.
GM said the deal will focus on domestic sales of Buick and Cadillac models in China and exporting Chevrolet products built in China for non-U.S. markets.